EUVIMEDObjevte EUVIMED
Crossref

Transcatheter Pulmonary Valve Replacement With a Novel Valve: Medium‐Term Results From a Single Center Study

Robin H S Chen iD, Timothy K C Un, Clement K M Yu, Alston Conrad Chiu iD, Pak-Cheong Chow iD, Kin-Shing Lun, Simon Lam, Adolphus K T Chau iD, John P Cheatham

Catheterization and Cardiovascular Interventions · 2026

DOI: 10.1002/ccd.70405 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2026. Written by Robin H S Chen and 8 co-authors. Institution: Cardiology Unit, Department of Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong. Major MEDLINE topics: Pulmonary Valve, Pulmonary Valve Insufficiency, Heart Valve Prosthesis Implantation, Cardiac Catheterization. 21 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Transcatheter pulmonary valve replacement (tPVR) has emerged as a promising management strategy for dysfunctional right ventricular outflow tract (RVOT). However, the management of chronic pulmonary regurgitation (PR) in native or patched RVOT remains challenging with the vast variation in morphology, leading to the demand for novel self‐expandable valves.

Objective

To report procedural performance and medium‐term follow‐up data of the Med Zenith PT‐Valve for tPVR in native or patched RVOT from a single‐center feasibility trial.

Methods

Fifteen patients with PR were recruited for candidacy assessment, with 12 tPVR procedures performed with per‐protocol follow‐up.

Results

Amongst patients recruited, one with concomitant aortic pathology was diverted to surgery; there was one screen failure (7.1%) and one patient withdrew consent. Twelve patients underwent tPVR with the study valve with 100% success rate. Complications included one wire‐related pulmonary hemorrhage, one transient brachial neuropraxia, one femoral pseudoaneurysm, and two patients with non‐sustained ventricular tachycardia Day 1 post‐tPVR. Both patients received a short course of a beta‐blocker without recurrence of arrhythmia. There were no deaths or valve‐related reinterventions with a median follow‐up of 28.5 months (range 17.9–40.0 months). One episode of infective endocarditis was managed conservatively with antibiotics with no sequelae. There were otherwise no late complications. Significant improvement in biventricular volume and PR fraction was observed.

Conclusion

The Med Zenith PT‐Valve has performed well over short to mid‐term follow‐up in patients with significant PR in native or patched RVOT. Future studies are required to elucidate the longevity of the valve.

Subjects

MeSH terms (MEDLINE)

Pulmonary ValvePulmonary Valve InsufficiencyHeart Valve Prosthesis ImplantationCardiac CatheterizationHeart Valve ProsthesisHumansTreatment OutcomeFemaleMaleTime FactorsFeasibility StudiesAdultProsthesis DesignMiddle AgedRecovery of FunctionYoung AdultChronic DiseaseAdolescentHemodynamicsVentricular Function, Right

Author keywords

native outflowpulmonary regurgitationtranscatheter valve

Authors and institutions

  • Cardiology Unit, Department of Medicine, Queen Mary Hospital, Pok Fu Lam, Hong Kong.
  • Cardiology Centre, Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Kowloon City, Hong Kong.
  • Department of Paediatrics, Chinese University of Hong Kong Medical Centre, Kowloon City, Hong Kong.
  • Pediatrics and Internal Medicine, Cardiology, The Ohio State University, Columbus, Ohio, USA.

ORCID profiles: Robin H S Chen, Alston Conrad Chiu, Pak-Cheong Chow, Adolphus K T Chau

Cite

APA

Chen, R. H. S., Un, T. K. C., Yu, C. K. M., Chiu, A. C., Chow, P. C., Lun, K. S., Lam, S., Chau, A. K. T., & Cheatham, J. P. (2026). Transcatheter Pulmonary Valve Replacement With a Novel Valve: Medium‐Term Results From a Single Center Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70405

Vancouver

Chen RHS, Un TKC, Yu CKM, Chiu AC, Chow PC, Lun KS, et al. Transcatheter Pulmonary Valve Replacement With a Novel Valve: Medium‐Term Results From a Single Center Study. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70405

BibTeX
@article{Chen2026,
  author = {Chen, Robin H S and Un, Timothy K C and Yu, Clement K M and Chiu, Alston Conrad and Chow, Pak-Cheong and Lun, Kin-Shing and Lam, Simon and Chau, Adolphus K T and Cheatham, John P},
  title = {Transcatheter Pulmonary Valve Replacement With a Novel Valve: Medium‐Term Results From a Single Center Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  doi = {10.1002/ccd.70405}
}
Start for free →